Ka‐On Lam

486 total citations
14 papers, 305 citations indexed

About

Ka‐On Lam is a scholar working on Otorhinolaryngology, Oncology and Surgery. According to data from OpenAlex, Ka‐On Lam has authored 14 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Otorhinolaryngology, 6 papers in Oncology and 5 papers in Surgery. Recurrent topics in Ka‐On Lam's work include Head and Neck Cancer Studies (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Viral-associated cancers and disorders (2 papers). Ka‐On Lam is often cited by papers focused on Head and Neck Cancer Studies (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Viral-associated cancers and disorders (2 papers). Ka‐On Lam collaborates with scholars based in China, Hong Kong and United States. Ka‐On Lam's co-authors include Victor Lee, To‐Wai Leung, Cheuk‐Wai Choi, Chi‐Chung Tong, Sum‐Yin Chan, Dora L.�W. Kwong, Wing‐Lok Chan, Sherry C.Y. Ng, Dora Lai‐Wan Kwong and Vincent Lai and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and International Journal of Cancer.

In The Last Decade

Ka‐On Lam

14 papers receiving 302 citations

Peers

Ka‐On Lam

ONCOL

OTORH

SURGE

PRM

Yecai Huang China

E. Haddad France

Timothy Cheo Singapore

Felix Ho United States

P. Canary Brazil

R. Axelrod United States

Marlinda Adham Indonesia

Ashwini Budrukkar India

Bin Qiu China

Sarah S. Kılıç United States

Yecai Huang China

Ka‐On Lam

87 ×0.6

ONCOL

98 ×0.7

OTORH

56 ×0.7

SURGE

97 ×1.5

PRM

34 ×0.6

Citations per year, relative to Ka‐On Lam Ka‐On Lam (= 1×) peers Yecai Huang

Countries citing papers authored by Ka‐On Lam

Since Specialization

Citations

This map shows the geographic impact of Ka‐On Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ka‐On Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ka‐On Lam more than expected).

Fields of papers citing papers by Ka‐On Lam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ka‐On Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ka‐On Lam. The network helps show where Ka‐On Lam may publish in the future.

Co-authorship network of co-authors of Ka‐On Lam

This figure shows the co-authorship network connecting the top 25 collaborators of Ka‐On Lam. A scholar is included among the top collaborators of Ka‐On Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ka‐On Lam. Ka‐On Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Gong, Lanqi, Yu Zhang, Qian Yan, et al.. (2022). Inhibition of lysyl oxidase‐like 2 overcomes adhesion‐dependent drug resistance in the collagen‐enriched liver cancer microenvironment. Hepatology Communications. 6(11). 3194–3211. 15 indexed citations

Chan, Wing‐Lok, Carlos King Ho Wong, Cheuk‐Wai Choi, et al.. (2021). Acceptance of COVID-19 Vaccination in Cancer Patients in Hong Kong: Approaches to Improve the Vaccination Rate. Vaccines. 9(7). 792–792. 22 indexed citations

Wong, Tiffany, Victor Lee, Herbert Pang, et al.. (2021). Prospective Study of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma on Waitlist for Liver Transplant. Hepatology. 74(5). 2580–2594. 38 indexed citations

Wong, Jeffrey Sum Lung, Ryohichi Sugimura, Ka‐On Lam, et al.. (2021). Recent Advances and Future Prospects in Immune Checkpoint (ICI)-Based Combination Therapy for Advanced HCC. Cancers. 13(8). 1949–1949. 36 indexed citations

Lam, Tai‐Chung, Xian Chen, Li Yang, et al.. (2020). Quality of end-of-life care of advanced cancer patients in mainland China—a retrospective cohort of 441 hospital-death in a public funded comprehensive hospital. Annals of Palliative Medicine. 9(6). 4514–4520. 3 indexed citations

Ko, Josephine Mun Yee, Wei Dai, Merrin Man‐Long Leong, et al.. (2018). Leukocyte telomere length associates with nasopharyngeal carcinoma risk and survival in Hong Kong Chinese. International Journal of Cancer. 143(9). 2289–2298. 5 indexed citations

Lee, Victor, Dora Lai‐Wan Kwong, To‐Wai Leung, et al.. (2018). The addition of pretreatment plasma Epstein–Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification. International Journal of Cancer. 144(7). 1713–1722. 80 indexed citations

Lee, Victor, Ka‐On Lam, Dora L.�W. Kwong, & To‐Wai Leung. (2016). Radiation recall after capecitabine in a patient with recurrent nasopharyngeal carcinoma: a case report. Journal of Medical Case Reports. 10(1). 247–247. 3 indexed citations

Lee, Victor, Sum‐Yin Chan, Cheuk‐Wai Choi, et al.. (2016). Dosimetric Predictors of Hypothyroidism After Radical Intensity-modulated Radiation Therapy for Non-metastatic Nasopharyngeal Carcinoma. Clinical Oncology. 28(8). e52–e60. 38 indexed citations

10.

Lee, Victor, Dora L.�W. Kwong, To‐Wai Leung, et al.. (2016). Hyperfractionation compared to standard fractionation in intensity-modulated radiation therapy for patients with locally advanced recurrent nasopharyngeal carcinoma. European Archives of Oto-Rhino-Laryngology. 274(2). 1067–1078. 14 indexed citations

11.

Lee, Victor, Dora Lai‐Wan Kwong, To‐Wai Leung, et al.. (2016). Prognostication of serial post-intensity-modulated radiation therapy undetectable plasma EBV DNA for nasopharyngeal carcinoma. Oncotarget. 8(3). 5292–5308. 39 indexed citations

12.

Lee, Victor, Dora L.�W. Kwong, To‐Wai Leung, et al.. (2015). Serial early post-IMRT undetectable plasma EBV DNA to predict outcomes in non-metastatic nasopharyngeal cancer.. Journal of Clinical Oncology. 33(15_suppl). 6007–6007. 1 indexed citations

13.

Lee, Victor, Raymond K. Tsang, Jimmy Yu Wai Chan, et al.. (2014). Treatment outcomes of postradiation second head and neck malignancies managed by a multidisciplinary approach. Head & Neck. 37(6). 815–822. 7 indexed citations

14.

Yau, Tsz‐Kok, Inda Soong, Ka‐On Lam, et al.. (2009). Toxicity of docetaxel plus cyclophosphamide as adjuvant therapy for breast cancer in Chinese patients – the Hong Kong experience. Asia-Pacific Journal of Clinical Oncology. 5(2). 123–128. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact